Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.
Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR.
Larkin KL, et al.
Br J Ophthalmol. 2014 Jan;98(1):99-103. doi: 10.1136/bjophthalmol-2013-304043. Epub 2013 Oct 24.
Br J Ophthalmol. 2014.
PMID: 24158837